Azacitidine and Pembrolizumab in Pancreatic Cancer

NCT03264404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Azacitidine

Sponsor

Susan E. Bates